NCT07346430

Brief Summary

children and adolescents with CP are at increased risk of developing mental health difficulties, particularly anxiety disorders, compared with their typically developing peers. this study was to investigate the correlation between anxiety, spasticity and balance in children with cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

January 8, 2026

Last Update Submit

January 16, 2026

Conditions

Keywords

anxietybalancespasticityfunctioncerebral palsy

Outcome Measures

Primary Outcomes (3)

  • function

    The Gross Motor Functional Measurement-88 used to measure function. The GMFM is a standardized observational instrument designed and validated to measure change in gross motor function over time in children with cerebral palsy. The scoring key is meant to be a general guideline. However, most of the items have specific descriptors for each score. It is imperative that the guidelines contained in the manual be used for scoring each item. SCORING KEY 0 = does not initiate 1. = initiates 2. = partially completes 3. = completes

    3 months

  • spasticity

    The modified Ashworth scale was used to measure spasticity. The test is performed by extending the patients limb's first from a position of maximal possible flexion to maximal possible extension (the point at which the first soft resistance is met). Afterwards, the modified Ashworth scale is assessed while moving from extension to flexion. Scoring 0 No Increased in tone 1. Slight increase in tone giving a catch when the limb is moved in flexion or extension 1+ Slight increase in muscle tone, indicated by a catch followed by minimal resistance throughout range of motion (ROM) 2. More marked increase in tone through most of the ROM, but the limb easily flexed 3. Considerable increase in tone, passive movement difficult 4. Limb rigid in flexion or extension

    3 months

  • balance

    3\. Biodex balance system was used to evaluate the postural stability and dynamic balance of children

    3 months

Eligibility Criteria

Age4 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

POWER statistical programming was used to test size estimation \[Exact Correlation: Bivariate normal model, α = 0.05, β = 0.20, number of variables = 2, correlation ρH0 = 0, correlation ρH1 = 0.81, and coefficient of determination ρ2 = 0.66 and shown that the suitable sample size of current study was N = 13\]. This coefficient of determination ρ2 was calculated from a pilot study of ten participants (between grades of spasticity and gross motor function).

You may qualify if:

  • age 4-8 years from both genders
  • diagnosed as hemiplegia and diplegia
  • Gross Motor Function Classification System (GMFCS) levels I or II
  • spasticity grade of 1 or I+ on the modified Ashworth Scale

You may not qualify if:

  • significant visual, auditory, or perceptual deficits
  • uncontrolled seizures
  • acute illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, 11432, Egypt

Location

MeSH Terms

Conditions

Cerebral PalsyAnxiety DisordersMuscle Spasticity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMental DisordersMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mostafa s Ali, PhD

    associate professor of physical therapy for pediatrics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

January 8, 2026

First Posted

January 16, 2026

Study Start

August 14, 2025

Primary Completion

November 10, 2025

Study Completion

December 30, 2025

Last Updated

January 20, 2026

Record last verified: 2026-01

Locations